Physician

Fausto Fabian Salinas, MD

According to 2025 Medicare claims, Fausto Salinas, MD (NPI: 1740243443) practices pulmonary disease in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is TUSCALOOSA LUNG & SLEEP CONSULTANTS, PC (NPI: 1447215561; TIN: 63-0778894) and primary practice location at 35401-2029.

Salinas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 473 traditional Medicare patients, billed 3,991 HCPCS/CPT codes, and received $261,693 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 2,371 prescription claims across 381 beneficiaries totaling $2,866,361 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 1,135 claims. Open Payments data shows 153 records totaling $2,660. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $491,820 to $261,693. In contrast, Part D prescription costs have moved sharply higher in recent years, from $188,610 to $2,866,361. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $121,284 and ending at $197,920.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$246K$492K2015 Medicare payment: $491,820 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $473,877 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $428,075 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $397,539 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $430,418 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $396,334 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $309,496 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $242,978 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $261,333 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $261,693 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158537,080$491,820
20169217,051$473,877
20177556,010$428,075
20187355,549$397,539
20196835,681$430,418
20206215,056$396,334
20215544,298$309,496
20224603,582$242,978
20234744,121$261,333
20244733,991$261,693

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.9M2015 Drug cost: $188,610 (USD; Tot_Drug_Cst)2016 Drug cost: $297,281 (USD; Tot_Drug_Cst)2017 Drug cost: $366,170 (USD; Tot_Drug_Cst)2018 Drug cost: $608,400 (USD; Tot_Drug_Cst)2019 Drug cost: $1,203,607 (USD; Tot_Drug_Cst)2020 Drug cost: $1,474,502 (USD; Tot_Drug_Cst)2021 Drug cost: $1,532,716 (USD; Tot_Drug_Cst)2022 Drug cost: $1,916,518 (USD; Tot_Drug_Cst)2023 Drug cost: $2,286,469 (USD; Tot_Drug_Cst)2024 Drug cost: $2,866,361 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151991,145$188,610
20162401,315$297,281
20172611,438$366,170
20182781,528$608,400
20193011,829$1,203,607
20203262,056$1,474,502
20213352,026$1,532,716
20223302,018$1,916,518
20233792,305$2,286,469
20243812,371$2,866,361

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$112K$224K2015 Medicare payment: $127,679 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $100,605 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $158,086 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $207,028 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $223,391 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $224,289 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $223,777 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $156,283 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $149,685 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $197,918 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151491,102$127,679
20161891,221$100,605
20172161,390$158,086
20181961,468$207,028
20192091,318$223,391
20201611,234$224,289
20211711,287$223,777
20221351,000$156,283
2023143990$149,685
20241491,135$197,918

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2511,268$85
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more230620$85
94729Test to examine how well the lungs exchange gases199249$36
94060Test to measure expiratory airflow and volume changes before and after medication administration219446$26
88738Hemoglobin measurement184224$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OfevNintedanib Esylate922,760$1,003,394
ActharCorticotropin13364$581,464
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29012,570$263,005
Breztri AerosphereBudesonide/Glycopyr/Formoterol1365,994$123,711
GlassiaAlpha-1-Proteinase Inhibitor52364$117,462

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0483High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, eachY1688$83,573
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)Y1183$69,195
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY42321$24,562
E1392Portable oxygen concentrator, rentalY32247$8,548
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R14$4,615

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.153$2,660AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Fausto Fabian Salinas, MD?

Tedicare shows public-source Medicare data for Fausto Fabian Salinas, MD (NPI 1740243443), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fausto Fabian Salinas, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Fausto Fabian Salinas, MD?

Fausto Fabian Salinas, MD is linked to TUSCALOOSA LUNG & SLEEP CONSULTANTS, PC (billing NPI 1447215561) in the available physician profile data.

Does Fausto Fabian Salinas, MD have Open Payments data?

Fausto Fabian Salinas, MD has 153 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.